August 28, 2026

FDA expands tirzepatide indication to cardiovascular risk reduction

SURPASS-CVOT compared tirzepatide head-to-head with dulaglutide in 13,299 participants.

MDSpire News

August 28, 2026

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

MDSpire News

August 26, 2026

FDA authorizes continuous ketone monitor

Patients aged 2 years and older with diabetes are eligible to use the wearable.

MDSpire News

August 20, 2026

FDA approves therapy for GSDIa

The one-time gene therapy is intended to restore the deficient enzyme needed to release stored glucose during fasting.

MDSpire News

August 20, 2026

How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages

“There is incredible uncertainty in drug dosing.”

Kff Health News

August 11, 2026

Patients Wary of Governments, Companies Pushing AI as a Rural Healthcare Solution

“The risk of signing contracts that rural healthcare organizations come to regret is pretty high.”

Kff Health News

August 10, 2026

HHS Proposes Mandatory GRAS Notices

Manufacturers would be required to notify the FDA of GRAS determinations under a proposed rule, while HHS and USDA also submitted the first proposed federal definition of ultra-processed foods for final review.

MDSpire News

July 22, 2026

Trump’s Personnel Agency Says It Will Remove Some Identifying Info as It Sweeps Up Medical Records

“Clearly, this administration has not earned our trust with Americans’ sensitive data."

Kff Health News

July 22, 2026

Trump’s Personnel Agency Says It Will Remove Some Identifying Info as It Sweeps Up Medical Records

“Clearly, this administration has not earned our trust with Americans’ sensitive data."

MDSpire News

July 16, 2026

FDA Approves First Oral PCSK9 Inhibitor

Merck reported placebo-adjusted LDL-C reductions of 56% and 59% at week 24 in two phase 3 CORALreef trials supporting the approval.

MDSpire News